Literature DB >> 14719190

Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis.

Alain Saraux1, Jean M Berthelot, Valérie Devauchelle, Boutahar Bendaoud, Gérard Chalès, Catherine Le Henaff, Jean B Thorel, Sylvie Hoang, Sandrine Jousse, Dominique Baron, Paul Le Goff, Pierre Youinou.   

Abstract

OBJECTIVE: To compare the diagnostic values of antiperinuclear factor (APF), antikeratin antibody (AKA), and anti-cyclic citrullinated peptides (anti-CCP) to discriminate between patients with and without rheumatoid arthritis (RA) and to determine the diagnostic value of anti-CCP used alone or with other tests.
METHODS: Two hundred and seventy patients with early arthritis underwent standardized investigations in 1995-1997. The clinical utility of APF, AKA, and anti-CCP in first-visit sera was evaluated using receiver-operating characteristic curves. Combinations of anti-CCP with other laboratory tests were assessed by multiple logistic regression.
RESULTS: Anti-CCP, APF, and AKA were not perfectly correlated with one another. Anti-CCP with 53 UI as the cutoff was 47% sensitive and 93% specific, versus 52% and 79%, and 47% and 94%, for APF and AKA, respectively. Multiple logistic regression selected anti-CCP, AKA, IgM-rheumatoid factor (RF) ELISA, and the latex test.
CONCLUSION: Rheumatologists can routinely use 2 or 3 tests for diagnosing RA (latex and/or IgM RF ELISA, and either AKA or anti-CCP ELISA) and can add a third or fourth test when the diagnosis remains in doubt.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14719190

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

Review 1.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Authors:  Rohit Aggarwal; Katherine Liao; Raj Nair; Sarah Ringold; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-11-15

2.  Predictive value of anti-citrullinated peptide antibodies: a real life experience.

Authors:  Abdulla Watad; Nancy Agmon-Levin; Boris Gilburd; Merav Lidar; Howard Amital; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

3.  Diagnostic accuracy of anti-keratin antibody for rheumatoid arthritis: a meta-analysis.

Authors:  Xue-Ping Wang; Qian-Yao Cheng; Ming-Ming Gu; Rui-Xue Leng; Yin-Guang Fan; Bao-Zhu Li; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2019-02-27       Impact factor: 2.980

4.  Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis.

Authors:  Xue Qin; Yan Deng; Jing Xu; Tai-Jie Li; Shan Li; Jin-Min Zhao
Journal:  Rheumatol Int       Date:  2010-03-10       Impact factor: 2.631

5.  Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.

Authors:  N Inanc; E Dalkilic; S Kamali; E Kasapoglu-Günal; Y Elbir; H Direskeneli; M Inanc
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 2.980

6.  The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases.

Authors:  Ct Chou; Ht Liao; Ch Chen; Ws Chen; Hp Wang; Ky Su
Journal:  Biomark Insights       Date:  2007-05-03

7.  Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: diagnostic value, association with radiological damage and axial skeleton affection.

Authors:  Howaida E Mansour; Khaled M Metwaly; Iman A Hassan; Hebat-Allah A Elshamy; Moataz M S Elbeblawy
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2010-05-24

Review 8.  Update on autoantibodies in rheumatoid arthritis.

Authors:  S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

9.  Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.

Authors:  Eriko Kudo-Tanaka; Shiro Ohshima; Masaru Ishii; Toru Mima; Masato Matsushita; Naoto Azuma; Yoshinori Harada; Yoshinori Katada; Hitomi Ikeue; Mitsuko Umeshita-Sasai; Kunio Miyatake; Yukihiko Saeki
Journal:  Clin Rheumatol       Date:  2007-02-08       Impact factor: 2.980

10.  A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis.

Authors:  Lisiane Maria Enriconi dos Anjos; Ivanio Alves Pereira; Eleonora d 'Orsi; Andrea Piette Seaman; Rufus Watson Burlingame; Edelton Flavio Morato
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.